Skip to content
MedsAcross

Manufacturer

Knoa Pharma

Products listed
20
Molecules
4
Therapy areas
2

Knoa Pharma is a pharmaceutical manufacturer based in an unrecorded country. MedsAcross lists 20 of its products across 4 molecules, each with registers, packs and availability for export supply to licensed buyers.

Indian manufacturer
No
Also listed as
Knoa Pharma LLC
US FDA labeler
YesSource: openFDA NDC directory

Source from this manufacturer

We supply Knoa Pharma products through licensed channels, with the documents your regulator needs.

Neurology

7 presentations

Neurology overview
MedicineActive ingredientRegisterAvailability
Butrans 10 mcg/hour transdermal patchTransdermalBuprenorphineUS FDAAvailable on request
Butrans 15 mcg/hour transdermal patchTransdermalBuprenorphineUS FDAAvailable on request
Butrans 20 mcg/hour transdermal patchTransdermalBuprenorphineUS FDAAvailable on request
Butrans 5 mcg/hour transdermal patchTransdermalBuprenorphineUS FDAAvailable on request
Butrans 7.5 mcg/hour transdermal patchTransdermalBuprenorphineUS FDAAvailable on request
Nalmefene 2 mg/2 mL injectionIntramuscular, intravenous, subcutaneousGeneric nameNalmefeneUS FDAAvailable on request
Zurnai 1.5 mg/0.5 mL injectionIntramuscular, subcutaneousNalmefeneUS FDAAvailable on request

Pain and anaesthesia

7 presentations

Pain and anaesthesia overview
MedicineActive ingredientRegisterAvailability
OxyContin 10 mg extended-release tabletOralOxycodoneUS FDAAvailable on request
OxyContin 15 mg extended-release tabletOralOxycodoneUS FDAAvailable on request
OxyContin 20 mg extended-release tabletOralOxycodoneUS FDAAvailable on request
OxyContin 30 mg extended-release tabletOralOxycodoneUS FDAAvailable on request
OxyContin 40 mg extended-release tabletOralOxycodoneUS FDAAvailable on request
OxyContin 60 mg extended-release tabletOralOxycodoneUS FDAAvailable on request
OxyContin 80 mg extended-release tabletOralOxycodoneUS FDAAvailable on request

Other products

6 presentations

MedicineActive ingredientRegisterAvailability
Hysingla ER 100 mg extended-release tabletOralHydrocodoneUS FDAAvailable on request
Hysingla ER 20 mg extended-release tabletOralHydrocodoneUS FDAAvailable on request
Hysingla ER 30 mg extended-release tabletOralHydrocodoneUS FDAAvailable on request
Hysingla ER 40 mg extended-release tabletOralHydrocodoneUS FDAAvailable on request
Hysingla ER 60 mg extended-release tabletOralHydrocodoneUS FDAAvailable on request
Hysingla ER 80 mg extended-release tabletOralHydrocodoneUS FDAAvailable on request

Molecules made

Manufacturer facts come from public registers and are shown with their source. Listing does not mean the manufacturer endorses MedsAcross.

Source from Knoa Pharma

Send a request for any of these products. We confirm the licensed source, documents and lead time.